70
https://pubmed.ncbi.nlm.nih.gov/38117905
Epistaxis (nosebleed) can be an early sign of lymphoproliferative disorder in dermatomyositis patients treated with methotrexate.
Epistaxis as Early Sign of Lymphoproliferative Disorder in Dermatomyositis Patients Treated with Methotrexate
